Phibro Animal Health | PAHC - Capital Ordinário





Capital Ordinário Alterar Data
Align Technology USD 71.62M 1000 2026-06
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 58.95M 2.24M 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 422.07M 53.78M 2026-03
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Henry Schein USD 111.92M 2.51M 2026-06
Idexx Laboratories USD 78.87M 366K 2026-06
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Merck USD 2.47B 4.93M 2026-03
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Pacira USD 39.82M 512K 2026-06
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.37M 53K 2026-06
Supernus Pharmaceuticals USD 58.16M 124K 2026-06
Zoetis USD 414.15M 6.19M 2026-06